We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Combining gemcitabine, oxaliplatin and capecitabine (GEMOXEL) for patients with advanced pancreatic carcinoma (APC): a phase I/II trial.
- Authors
Hess, V; Pratsch, S; Potthast, S; Lee, L; Winterhalder, R; Widmer, L; Cescato, C; Lohri, A; Jost, L; Stillhart, P; Pestalozzi, B; Herrmann, R
- Abstract
Gemcitabine remains the mainstay of palliative treatment of advanced pancreatic carcinoma (APC). Adding capecitabine or a platinum derivative each significantly prolonged survival in recent meta-analyses. The purpose of this study was to determine dose, safety and preliminary efficacy of a first-line regimen combining all three classes of active cytotoxic drugs in APC.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Vol 21, Issue 12, p2390
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdq242